Agenda
Day 1
Tuesday, November 19, 2024
12:00PM-7:00PM
12:30-12:35PM Welcome Address
David Cassak, Editor-in-Chief, MedTech Strategist
Stephen Levin, Editor-in-Chief, Market Pathways
12:35-1:15PM Raising Capital from Strategics
Todd Brinton, Chief Scientific Officer & Corporate Vice President, Edwards Lifesciences
Vivian Golfin (De Ruijter), Senior Associate, Intuitive Ventures
Abigail Hunter-Syed, Director, Olympus Innovation Ventures
Biren Mehta, Vice President, Venture Investments, MedTech, JJDC - Johnson & Johnson Development Corp.
Gowri Raman, Director of Venture Capital, Medtronic
David Cassak, Editor-in-Chief, MedTech Strategist
1:15-1:20PM Sponsor Moderator - Medmarc
1:20-1:30PM CAPS Medical
1:30-1:40PM ATRO Medical
1:40-1:50PM SynerFuse
1:50-2:00PM SpinaFX Medical
2:00-2:10PM Eyedaptic
2:10-2:20PM Magsorbeo Biomedical
2:20-2:40PM Networking Break --
2:40-3:10PM Clinical Trials for Today’s FDA: Diversity, Digital, and Novel Designs
Tim Marjenin, Vice President, Neurology Regulatory Affairs, MCRA, an IQVIA business
Kenneth Rayl, Director, Clinical Affairs, MCRA, an IQVIA Business
David Filmore, Executive Editor, Market Pathways (moderator)
3:10-3:15PM Sponsor Moderator - Latham & Watkins
3:15-3:25PM Cooler Heads
3:25-3:35PM Cardiostory
3:35-3:45PM Katomed
3:45-3:55PM Novuson Surgical
3:55-4:05PM EnClear Therapies
4:10-4:40PM Medtech 3.0 & Creating the Next Unicorns
Scott Huennekens, Principal, Front Foot Ventures
Stephen Levin, Editor-in-Chief, Market Pathways
4:40-5:45PM MedTech Innovator Value Competition
Flow Medical
Cellular Vehicles
CranioSense
myBiometry
iCE NeuroSystems
Paul Grand, CEO, MedTech Innovator (Host)
5:45-7:00MPM Networking Reception - Grand Peninsula Foyer
Day 2
Wednesday, November 20, 2024
8:30AM-7:15PM
8:15-8:45AM Registration & Continental Breakfast –Foyer
8:45-9:25AM Understanding Today’s M&A Environment:
Chris Eso, Vice President, Global Head Corporate and Business Development & Ventures, Medtronic
Mirren Mandalia, Senior Director, Business Development, J&J MedTech
David Cassak, Editor-in-Chief, MedTech Strategist (moderator)
9:30-9:35AM Sponsor Moderator - IQVIA Medtech
9:35-9:45AM CraniUS Therapeutics
9:45-9:55AM Precision Epigenomics
9:55-10:05AM VenstraMedical
10:05-10:15AM Panda Surgical
10:15-10:35AM Networking Break
10:35-11:15AM Cracking the Black Hole of Private Payer Reimbursement
Perry Bridger, Senior Advisor, Public Affairs, Edwards Lifesciences
Mike Carusi, General Partner, Lightstone Ventures
Harry Kotlarz, Vice President, HEPV, MDIC
Stephen Levin, Editor-in-Chief, Market Pathways
11:15-11:20AM Sponsor Moderator - Rev.1 Engineering
11:20-11:30AM Vitazi.ai
11:30-11:40AM Peerbridge Health
11:40-11:50AM Tempo Therapeutics
11:50-12:00PM Hy2Care BV
12:00-12:40PM IP Trends in Medical Devices
Paul Conover, Partner, Knobbe Martens
Irfan Lateef, Partner, Knobbe Martens
12:40-1:50PM Lunch
1:55-2:35PM The Dynamics of Venture Investing Today
Erik Engelson, Venture Partner, ShangBay Capital
Tom Shehab, Managing Partner, Arboretum Ventures
Amrinder Singh, Partner, Vensana Capital
David Cassak, Editor-in-Chief, MedTech Strategist (moderator)
2:35-2:40PM Sponsor Moderator - Atlantia Clinical Trials
2:40-2:50PM Centese
2:50-3:00PM Orion Innovations
3:00-3:10PM Nostics
3:10-3:20PM Solenic Medical
3:20-3:30PM Atraverse Medical
3:30-3:50PM Networking Break
3:50-4:30PM The Ajax Model: A Middle Path to Innovation
Luke Rohlen, Associate, Ajax Health
Greg Schiffenhaus, Chief of Staff to CEO, Cordis
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
4:30-5:10PM Challenges and Opportunities in Robotic Surgery:
Josh DeFonzo, Co-founder and CEO, Mendaera
David Noonan, CTO, Moon Surgical
Vivian Golfin (De Ruijter), Senior Associate, Intuitive Ventures
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
5:10-6:10PM MedTech Innovator Finals Competition - Mid-Stage Startups
Somnics Health
Ozlo
LATTICE MEDICAL
Arsenal Medical
Paul Grand, CEO, MedTech Innovator (Host)
6:10-7:15PM Reception - Grand Peninsula Foyer
Day 3
Thursday, November 21, 2024
8:30AM-2:00PM
8:15-8:45AM Continental Breakfast
8:45-9:25AM Getting Funding From New Sources
Greg Garfield, Senior Managing Director, KCK Group
Bill Little, EVP, Corporate Development and Strategy, Orchestra Biomed
Chris Neil, MedTech, Partner, Advantage Fund
Stephen Levin, Editor-in-Chief, Market Pathways
9:25-9:30AM Sponsor Moderator - MedTech Strategist
9:30-9:40AM ATDev
9:40-9:50AM Focused Therapeutics
9:50-10:00AM Zepto Life Technology
10:00-10:10AM iCE Neurosystems
10:10-10:20AM InkSpace Imaging
10:20-10:40AM Networking Break
10:40-11:20AM Early-Stage Investments
Don Bobo, Corporate Vice President, Strategy & Corporate Development, Edwards Lifesciences
Justin Takashi Fukuyama, Partner, MedVenture Partners
Kwame Ulmer, Venture Partner, Wavemaker Three-Sixty Health
James Huie, Partner, Wilson Sonsini Goodrich & Rosati (moderator)
11:20-12:00PM MedTech Policy in 2025: A Post-Election Outlook on Industry Priorities
Mark Leahey, President & CEO, MDMA
Scott Whitaker, President & CEO, AdvaMed
David Filmore, Executive Editor, Market Pathways (moderator)
12:15-1:00PM Box Lunch - Grand Peninsula Foyer
